157 related articles for article (PubMed ID: 12177685)
1. Ensaculin (KA-672 HCl): a multitransmitter approach to dementia treatment.
Hoerr R; Noeldner M
CNS Drug Rev; 2002; 8(2):143-58. PubMed ID: 12177685
[TBL] [Abstract][Full Text] [Related]
2. Oral post-lesion administration of 5-HT(1A) receptor agonist repinotan hydrochloride (BAY x 3702) attenuates NMDA-induced delayed neuronal death in rat magnocellular nucleus basalis.
Harkany T; Mulder J; Horvath KM; Keijser J; van der Meeberg EK; Nyakas C; Luiten PG
Neuroscience; 2001; 108(4):629-42. PubMed ID: 11738499
[TBL] [Abstract][Full Text] [Related]
3. Generalization of serotonin (5-HT)1A agonists and the antipsychotics, clozapine, ziprasidone and S16924, but not haloperidol, to the discriminative stimuli elicited by PD128,907 and 7-OH-DPAT.
Dekeyne A; Rivet JM; Gobert A; Millan MJ
Neuropharmacology; 2001 Jun; 40(7):899-910. PubMed ID: 11378160
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and pharmacological evaluation of 1-[(1,2-diphenyl-1H-4-imidazolyl)methyl]-4-phenylpiperazines with clozapine-like mixed activities at dopamine D(2), serotonin, and GABA(A) receptors.
Asproni B; Pau A; Bitti M; Melosu M; Cerri R; Dazzi L; Seu E; Maciocco E; Sanna E; Busonero F; Talani G; Pusceddu L; Altomare C; Trapani G; Biggio G
J Med Chem; 2002 Oct; 45(21):4655-68. PubMed ID: 12361392
[TBL] [Abstract][Full Text] [Related]
5. BAY X 3702.
Drugs R D; 1999 Jan; 1(1):16-7. PubMed ID: 10565971
[No Abstract] [Full Text] [Related]
6. Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states.
Millan MJ; Newman-Tancredi A; Audinot V; Cussac D; Lejeune F; Nicolas JP; Cogé F; Galizzi JP; Boutin JA; Rivet JM; Dekeyne A; Gobert A
Synapse; 2000 Feb; 35(2):79-95. PubMed ID: 10611634
[TBL] [Abstract][Full Text] [Related]
7. Acute effect of KA-672, a putative cognitive enhancer, on neurotransmitter receptor binding in mouse brain.
Reisner E; Nöldner M; Rossner S; Chatterjee SS; Bigl V; Schliebs R
Neurosci Lett; 1999 Oct; 274(3):187-90. PubMed ID: 10548421
[TBL] [Abstract][Full Text] [Related]
8. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A
J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549
[TBL] [Abstract][Full Text] [Related]
9. PD 158771, a potential antipsychotic agent with D(2)/D(3) partial agonist and 5-HT(1A) agonist actions. I. Neurochemical effects.
Akunne HC; Zoski KT; Davis MD; Cooke LW; Meltzer LT; Whetzel SZ; Shih YH; Wustrow DJ; Wise LD; MacKenzie RG; Georgic LM; Heffner TG; Pugsley TA
Neuropharmacology; 2000 Apr; 39(7):1197-210. PubMed ID: 10760362
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationships of a new model of arylpiperazines. 5. Study of the physicochemical influence of the pharmacophore on 5-HT(1a)/alpha(1)-adrenergic receptor affinity: synthesis of a new derivative with mixed 5-HT(1a)/d(2) antagonist properties.
López-Rodríguez ML; Morcillo MJ; Fernández E; Porras E; Orensanz L; Beneytez ME; Manzanares J; Fuentes JA
J Med Chem; 2001 Jan; 44(2):186-97. PubMed ID: 11170628
[TBL] [Abstract][Full Text] [Related]
11. New pyridobenzodiazepine derivatives: modifications of the basic side chain differentially modulate binding to dopamine (D(4.2), D(2L)) and serotonin (5-HT(2A)) receptors.
Liégeois JF; Eyrolles L; Ellenbroek BA; Lejeune C; Carato P; Bruhwyler J; Géczy J; Damas J; Delarge J
J Med Chem; 2002 Nov; 45(23):5136-49. PubMed ID: 12408724
[TBL] [Abstract][Full Text] [Related]
12. S-100beta protects cultured neurons against glutamate- and staurosporine-induced damage and is involved in the antiapoptotic action of the 5 HT(1A)-receptor agonist, Bay x 3702.
Ahlemeyer B; Beier H; Semkova I; Schaper C; Krieglstein J
Brain Res; 2000 Mar; 858(1):121-8. PubMed ID: 10700604
[TBL] [Abstract][Full Text] [Related]
13. 1-Substituted-4-[3-(1,2,3,4-tetrahydro-5- or 7-methoxynaphthalen-1-yl)propyl]piperazines: influence of the N-1 piperazine substituent on 5-HT1A receptor affinity and selectivity versus D2 and alpha1 receptors. Part 6.
Perrone R; Berardi F; Colabufo NA; Leopoldo M; Tortorella V
Bioorg Med Chem; 2000 May; 8(5):873-81. PubMed ID: 10881999
[TBL] [Abstract][Full Text] [Related]
14. Substituted phenoxyalkylpiperazines as dopamine D3 receptor ligands.
Laszlovszky I; Acs T; Kiss B; Domány G
Pharmazie; 2001 Apr; 56(4):287-9. PubMed ID: 11338664
[TBL] [Abstract][Full Text] [Related]
15. Effects of ensaculin on dopamine metabolite levels and K(+)-induced glutamate release.
Teismann P; Ferger B
Eur J Pharmacol; 2000 Jun; 398(2):247-50. PubMed ID: 10854836
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the novel drug Ensaculin with MK-801 on the reduction of hydroxyl radical production in rat striatum after local application of glutamate.
Teismann P; Ferger B
Brain Res; 2000 Feb; 857(1-2):165-71. PubMed ID: 10700564
[TBL] [Abstract][Full Text] [Related]
17. New arylpiperazine derivatives with high affinity for alpha1A, D2 and 5-HT2A receptors.
González-Gómez JC; Santana L; Uriarte E; Brea J; Villazón M; Loza MI; De Luca M; Rivas ME; Montenegro GY; Fontenla JA
Bioorg Med Chem Lett; 2003 Jan; 13(2):175-8. PubMed ID: 12482418
[TBL] [Abstract][Full Text] [Related]
18. The putative cognitive enhancer KA-672.HCl is an uncompetitive voltage-dependent NMDA receptor antagonist.
Lishko PV; Maximyuk OP; Chatterjee SS; Nöldner M; Krishtal OA
Neuroreport; 1998 Dec; 9(18):4193-7. PubMed ID: 9926872
[TBL] [Abstract][Full Text] [Related]
19. A review of the neuroprotective properties of the 5-HT1A receptor agonist repinotan HCl (BAYx3702) in ischemic stroke.
Berends AC; Luiten PG; Nyakas C
CNS Drug Rev; 2005; 11(4):379-402. PubMed ID: 16614737
[TBL] [Abstract][Full Text] [Related]
20. Phenylpiperazine derivatives with strong affinity for 5HT1A, D2A and D3 receptors.
Terán C; Santana L; Uriarte E; Fall Y; Unelius L; Tolf BR
Bioorg Med Chem Lett; 1998 Dec; 8(24):3567-70. PubMed ID: 9934472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
